GGrantIndex
Sort

48,018 grants matching immunotherapy

System Dynamics of PD-1 Signaling in T Cells

$785,302
William S. Hlavacek · Triad National Security, Llc · R01 · FY2023 · AI

Allergen Loaded Nanoparticles for Food Allergy Tolerance

$785,246
Lonnie D Shea · University Of Michigan At Ann Arbor · R01 · FY2020 · AI

Mechanisms of myocarditis and progressive cardiac fibrosis in chronic Trypanosoma cruzi infection.

$785,194
Kathryn Marie Jones · Baylor College Of Medicine · R01 · FY2023 · AI

Molecular Targeted Photoimmunotherapy for Bladder Cancer

$785,005
Piyush Agarwal · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

A Human Antibody as an Immunotherapy for Cocaine Abuse (DP1)

$785,000
Andrew B Norman · University Of Cincinnati · DP1 · FY2010 · DA

Mechanisms of Chronic Hepatitis B Infection and Therapeutic Vaccines

$784,979
David R. Milich · Vaccine Research Institute Of San Diego · R01 · FY2010 · AI

Assessment of ultrasound-facilitated neurotherapeutics in Alzheimer's disease

$784,859
Elisa E Konofagou · Columbia University Health Sciences · R56 · FY2024 · AG

Epigenome-wide association study of childhood asthma

$784,641
Pandurangan Vijayanand · La Jolla Institute For Immunology · R01 · FY2021 · AI

System Dynamics of PD-1 Signaling in T Cells

$784,623
William S. Hlavacek · Triad National Security, Llc · R01 · FY2021 · AI

TURNING BREAST CANCER CELLS AGAINST THEMSELVES AS THE NEXT-GENERATION IMMUNOTHERAPY

$784,602
Dana-Farber Cancer Institute, Inc. · · FY2025 · Defense Health Agency

Basis for Success of Multidrug-Resistant Enterobacteriaceae

$784,503
Frank Deleo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI

Identification and eliminationof HIV reservoirs in oral lymphoid tissues by engineered NK cells.

$784,261
Jonathan Karn · Case Western Reserve University · R01 · FY2015 · DE

Role of Th17 in Severe and Recurrent C. difficile Infection

$784,076
William A Petri · University Of Virginia · R01 · FY2022 · AI

Understanding and Mitigating Vascular Side-Effects Associated with Anti-Amyloid Immunotherapy

$783,917
Cynthia A Lemere · Brigham And Women'S Hospital · R01 · FY2025 · NS

Chemoenzymatic glycan editing for deciphering biological functions of glycans

$783,616
Peng Wu · Scripps Research Institute, The · R35 · FY2021 · GM

Preclinical development of breakthrough immunotherapy for brain tumors

$783,609
Hideho Okada · University Of California, San Francisco · R35 · FY2025 · NS

Mechanisms of myocarditis and progressive cardiac fibrosis in chronic Trypanosoma cruzi infection.

$783,532
Kathryn Marie Jones · Baylor College Of Medicine · R01 · FY2022 · AI

The Landscape of Tumor intrinsic Genetic Resistance to T cell Therapy

$783,430
Christian Hinrichs · Rutgers Biomedical And Health Sciences · R00 · FY2023 · CA

The Landscape of Tumor intrinsic Genetic Resistance to T cell Therapy

$783,430
Christian Hinrichs · Rutgers Biomedical And Health Sciences · R00 · FY2025 · CA

The Landscape of Tumor intrinsic Genetic Resistance to T cell Therapy

$783,430
Christian Hinrichs · Rutgers Biomedical And Health Sciences · R00 · FY2024 · CA

Bioactive Metabolites Modulate Immune-Related Adverse Events in Cancer Immunotherapy

$783,417
Sonia Sharma · La Jolla Institute For Immunology · R01 · FY2021 · CA

Role of Th17 in Severe and Recurrent C. difficile Infection

$783,404
William A Petri · University Of Virginia · R01 · FY2023 · AI

YALE CANCER CENTER CALABRESI IMMUNO-ONCOLOGY TRAINING PROGRAM

$783,348
Harriet M Kluger · Yale University · K12 · FY2025 · CA

YALE CANCER CENTER CALABRESI IMMUNO-ONCOLOGY TRAINING PROGRAM

$783,348
Harriet M Kluger · Yale University · K12 · FY2024 · CA

Structure, Function and Mechanistic Analysis of LAG3

$783,023
Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AI